Pulmonary Disease Doctors in Concord, MA Accepting Medicare

6 Pulmonary Disease doctors found. Showing 1 - 6

Neha Mehta, DO Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 131 Ornac Ste 610, Concord, MA 01742 Phone: 978-371-7778

Peter M Barkin, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 131 Ornac, Suite 660, Concord, MA 01742 Phone: 978-369-4238    Fax: 978-369-8323

Dr. Meena Mehta, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 131 Ornac, Suite 610, Concord, MA 01742 Phone: 978-371-7778    Fax: 978-369-9514

Lynn B Weigel, MP Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 80 Beharrell St # 80a, Concord, MA 01742 Phone: 781-259-9292    Fax: 781-259-0747

David Stephen Green, MD Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 330 Baker Ave, Concord, MA 01742 Phone: 978-287-9350

Thomas S Johnson, M.D. Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: Damonmill Square, Suite 6a, Concord, MA 01742 Phone: 978-318-9799

News Archive

Curemark closes $6.5 million Series A round of funding

Curemark, a privately held drug research and development company, announced today that it has closed a $6.5M Series A round of funding.

NIAID to launch 2009 H1N1 influenza vaccine trials

Scientists in a network of medical research institutions across the United States are set to begin a series of clinical trials to gather critical data about influenza vaccines, including two candidate H1N1 flu vaccines. The research will be under the direction of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

Two genes linked to binge drinking

University of Maryland School of Medicine researchers have identified two genes associated with binge drinking that may open doors to new, more effective treatments for excessive alcohol drinking. The scientists found that manipulating two receptors in the brain, GABA receptors and toll-like receptor 4 (TLR4), "caused profound reduction" of binge drinking for two weeks in rodents that had been bred and trained to drink excessively. The study was published online the week of Feb. 28 in the journal the Proceedings of the National Academy of Sciences.

Nuron Biotech announces acquisition of Meningitec from Pfizer

Nuron Biotech Inc., a specialty biologics and vaccines company, today announced it has acquired from Pfizer Inc. Meningitec, which is a vaccine for the prevention of invasive disease caused by Neisseria meningitidis serogroup C.

ARVO urges Congress to reject budget proposal that seeks to cut NIH funding

The Association for Research in Vision and Ophthalmology urges Congressional leaders to reject the U.S. administration's recent FY18 budget proposal, which seeks to drastically cut National Institute of Health funding by nearly $6 billion, or 20%.

Read more Medical News

› Verified 2 days ago